Date: October 17, 2023
Time: 6:00 AM (PDT), 9:00 AM (EDT), 3:00 PM (CEST)
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinical case studies. They will also detail the results of a recently published observational study on the diagnostic accuracy of the T2MR assays in the ICU.
Learning Objectives
- Describe the clinical utility of the T2Bacteria and T2Resistance Panels in the ICU
- Demonstrate the accuracy of T2MR assays as point-of-care tests
- Discuss real-world clinical cases on panel application in the severely ill population
*T2Resistance has not yet been reviewed by the FDA for clearance but is commercially available outside of the United States as a CE-marked product
Webinars will be available for unlimited on-demand viewing after the live event.